Home » Topics » BioWorld Science

BioWorld Science
RSS

BUB1 biallelic mutations seen to cause microcephaly and developmental delay

Jan. 26, 2022

Molecular mimicry triggers multiple sclerosis

Jan. 25, 2022

Anixa and MolGenie report in vitro data on SARS-CoV-2 protease inhibitor

Jan. 25, 2022

AB1 protein targets TP53-mutated gastrointestinal tumors

Jan. 25, 2022

ImmVira leverages viral vectors to enable CAR-T therapy for solid tumors

Jan. 25, 2022

KIN-3248 shows efficacy against tumors with clinically relevant FGFR mutations

Jan. 25, 2022

PL-8177 shows promise in preclinical models of induced colitis

Jan. 25, 2022

Qualigen to develop G4-selective transcription inhibitor from UCL for cancer

Jan. 25, 2022

CBD inhibits SARS-CoV-2 replication during early stages of infection in mice

Jan. 25, 2022

Shanghai Newsky Biotechnology identifies PLA2G7 inhibitors

Jan. 25, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026